Clinical Trials Market Scope And Analysis

  • Report Code : TIPRE00006203
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 211
Buy Now

Clinical Trials Market Analysis, Size, and Growth (2023-2028)

Buy Now

Clinical Trials Market Report Clinical Trials Market Size and Share Clinical Trials Market Scope and Analysis

Clinical Trials Market Report Scope

Report Attribute Details
Market size in 2023 US$ 43.37 Billion
Market Size by 2031 US$ 73.33 Billion
Global CAGR (2023 - 2031) 6.8%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Study Design
  • Interventional Trials
  • Expanded Access Trials
By Indications
  • Autoimmune Diseases/Inflammation
  • Pain Management
  • Oncological Conditions
  • Neurological Disorders
  • Diabetes
  • Obesity
  • Metabolic Disorders
  • Cardiovascular Diseases
By Phase Type
  • Phase I
  • Phase II
  • Phase III
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • IQVIA Holdings Inc
  • Parexel International Corporation
  • IXICO Plc
  • Charles River Laboratories Inc
  • ICON Plc
  • WuXi AppTec Co Ltd
  • SGS SA
  • Syneos Health Inc
  • SIRO Clinpharm Private Limited
  • Thermo Fisher Scientific Inc

    • Clinical Trials Market News and Recent Developments

    The clinical trials market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the market are listed below:

    • Oracle announced new capabilities in Oracle Clinical One Randomization and Trial Supply Management (RTSM). With new enhancements for use, access, and regionalization, Clinical One RTSM users can address dynamic, country-specific regulatory requirements, and gain speed, reliability, and transparency in trials from commencement to closeout. (Source: Oracle Corp, Company Website, May 2024)
    • Parexel and Palantir Technologies Inc., a leading builder of artificial intelligence (AI) systems, entered into a multiyear strategic partnership to leverage AI to aid in enhanced, accelerated, safe, and effective clinical trials worldwide. Under this collaboration, Parexel leverages Palantir's Foundry and Artificial Intelligence Platform (AIP) to power its clinical data platform focused on driving clinical trial efficiency while maintaining the highest level of safety and regulatory rigor. (Source: Parexel International Corp, Company Website, April 2024)

    Clinical Trials Market Report Coverage and Deliverables

    The "Clinical Trials Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:

    • Clinical trials market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Clinical trials market trends, as well as market dynamics such as drivers, restraints, and key opportunities
    • Detailed PEST and SWOT analysis
    • Clinical trials market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the clinical trials market
    • Detailed company profiles